Hong WS - Search Results

1

Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.

Son YS, Suh JM, Ahn SH, Kim JC, Yi JY, Hur KC, Hong WS, Muller MT, Chung IK. Son YS, et al. Among authors: hong ws. Cancer Chemother Pharmacol. 1998;41(5):353-60. doi: 10.1007/s002800050751. Cancer Chemother Pharmacol. 1998. PMID: 9523730

2

Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.

Hong WS, Son YS. Hong WS, et al. Anticancer Res. 1996 Sep-Oct;16(5A):3031-6. Anticancer Res. 1996. PMID: 8917423

3

Effect of non-tumor cell contamination on detection of p53 gene mutations in human gastric cancer cells by polymerase chain reaction single-strand conformation polymorphism analysis.

Hong WS, Hong SI, Lee DS, Son Y. Hong WS, et al. Among authors: hong si. Korean J Intern Med. 1994 Jan;9(1):20-4. doi: 10.3904/kjim.1994.9.1.20. Korean J Intern Med. 1994. PMID: 8038143 Free PMC article.

4

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.

Hong SI, Park IC, Son YS, Lee SH, Kim BG, Lee JI, Lee TW, Kook YH, Min YI, Hong WS. Hong SI, et al. Among authors: hong ws. J Korean Med Sci. 1996 Feb;11(1):33-7. doi: 10.3346/jkms.1996.11.1.33. J Korean Med Sci. 1996. PMID: 8703368 Free PMC article.

5

Overexpression of tissue inhibitors of metalloproteinase-1 and -2 in the stroma of gastric cancer.

Hong SI, Park IC, Hong WS, Son YS, Lee SH, Lee JI, Choi DW, Moon NM, Choe TB, Jang JJ. Hong SI, et al. Among authors: hong ws. J Korean Med Sci. 1996 Dec;11(6):474-9. doi: 10.3346/jkms.1996.11.6.474. J Korean Med Sci. 1996. PMID: 9008095 Free PMC article.

6

Peripheral blood lymphocyte subsets in patients with stomach cancer.

Hong WS, Min YI, Son YS, Hong SI. Hong WS, et al. Among authors: hong si. J Korean Med Sci. 1995 Jun;10(3):164-8. doi: 10.3346/jkms.1995.10.3.164. J Korean Med Sci. 1995. PMID: 8527041 Free PMC article.

7

Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.

Hong WS, Hong SI, Park SY, Son Y, Lee YS, Chung YH, Yang SK, Suh DJ, Min YI. Hong WS, et al. Among authors: hong si. Anticancer Res. 1995 Nov-Dec;15(6B):2777-80. Anticancer Res. 1995. PMID: 8669863

8

Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.

Hong WS, Jung HY, Yang SK, Kim HR, Min YI. Hong WS, et al. Anticancer Res. 1997 Sep-Oct;17(5A):3613-6. Anticancer Res. 1997. PMID: 9413212

9

Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells.

Hong WS, Kim CM, Lee CT, Lee JO, Kang TW. Hong WS, et al. J Korean Med Sci. 1992 Sep;7(3):236-40. doi: 10.3346/jkms.1992.7.3.236. J Korean Med Sci. 1992. PMID: 1285922 Free PMC article.

10

Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.

Kim DK, Kim HT, Cho YB, Tai JH, Ahn JS, Kim TS, Kim KH, Hong WS. Kim DK, et al. Among authors: hong ws. Cancer Chemother Pharmacol. 1995;35(5):441-5. doi: 10.1007/s002800050260. Cancer Chemother Pharmacol. 1995. PMID: 7850928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters